Bonescreen offers AI-based technology for non-invasive extraction of biomarkers from existing medical images, assisting radiologists and clinicians in diagnosing conditions like osteoporosis.

Bonescreen

bonescreen | 682 followers on LinkedIn. Building prevention with evidence-based AI. | Bonescreen is a MedTech software company based in Munich. As a spin-off of the Technical University of Munich, the team is committed to contributing to a value-based healthcare system. 

Bonescreen provides non-invasive spinal biomarker extraction and analysis to assist radiologists and clinicians in evaluating diseases related to bone health.

Co-founder and CPO at Bonescreen GmbH | Research Scientist | Machine Learning Expert | Medical Image Analysis | Software Engineer | NLP

Giles Ekow Tetteh

CTO & Co-founder at bonescreen

Malek Husseini

Co-Founder at Bonescreen I Neuroradiology Resident & Clinician Scientist

Sebastian Rühling

Neuroradiologe, Forscher und Entrepreneur

Jan Kirschke

bonescreen

Evidenzbasierte KI: Bayern investiert in Bonescreen und das TUM Universitätsklinikum! Das gemeinsame Projekt, geleitet von bonescreen in Zusammenarbeit mit den Abteilungen für Neurochirurgie und Neuroradiologie des TUM Universitätsklinikum Klinikum rechts der Isar , hat für die kommenden Jahre eine Förderung des Bayerischen Staatsministeriums (via Bayern Innovativ GmbH ) erhalten, einer Schlüsselinitiative des Freistaats Bayern. In Zusammenarbeit mit Experten des TUM Universitätsklinikums soll das opportunistische Screening am Universitätsklinikum erweitert werden, um den behandelnden Ärztinnen und Ärzten quantitative Daten zur Knochengesundheit in Echtzeit bereitzustellen. Ein Ziel des Projekts ist es, mit den KI-Lösungen von Bonescreen eine verbesserte und personalisierte OP-Planung zu ermöglichen. „Wir wollen gemeinsam insbesondere dazu beitragen, postoperative Komplikationen zu reduzieren und die individuelle Patientenversorgung zu verbessern“, sagt Priv.-Doz. Dr. Arthur Wagner, leitender Oberarzt der Neurochirurgie und Projektleiter auf neurochirurgischer Seite. Die Investition Bayerns unterstreicht auch das öffentliche Interesse an diesem Projekt: präventive und reproduzierbare KI-Diagnostik birgt das Potenzial für langfristige Kosteneinsparungen im Gesundheitswesen und eine verbesserte Patientenversorgung. Wir freuen uns sehr auf die Zusammenarbeit! Dr. Markus Söder Future of Health Grant EIT Health International Osteoporosis Foundation TUM Venture Labs

What about the EU AI Act? Have you ever been in the middle of a conversation and thought to yourself, “Why are we not recording this?!” That happened to me with Anjany from bonescreen who was on a panel yesterday at LSI discussing the European AI Act. Not being a true software guy, this is my translation… The EU AI Act primarily imposes new regulatory requirements for companies utilizing artificial intelligence in their products, especially in high-risk sectors like healthcare. MedTech companies that are already familiar with EUMDR will likely face additional checks and compliance measures specifically for the AI components of their devices, like algorithm transparency, bias prevention, and continuous performance monitoring to ensure patient safety. For companies already embedded in the regulated healthcare ecosystem, however, the incremental burden might be modest compared to industries that are newer to regulation. So, in that case, the focus is more along the lines of adapting existing compliance processes (audits, traceability, & documentation) to integrate AI-specific questions. If you’re an AI company, I’m curious what kind of impact you’ve felt from the AI Act – let me know! P.S. If you were having Medtech conversations in a monastery, you’d record every conversation too! 😂 #ai #medicaldevices #lsieurope24 #greenlightguru

Etienne Nichols

We are thrilled and honoured to be one of the 8 startups selected from over 200 applicants to join the Future of Health Grant 2024 cohort at Level 2! 🙌 Under expert mentorship, we are eager to collaborate with health service providers and insurance companies to enhance patient access to preventive bone health screenings in Switzerland. A big thank you to EPFL Innovation Park , CSS , and all the FoHG partners – we look forward to a productive journey together! 🚀

The European Union’s AI Act represents one of the most comprehensive regulatory frameworks for artificial intelligence to date. But what does this mean for startups, innovation, and investment in the Medtech sector? In our upcoming #LSIEurope24 panel, "The EU AI Act: Implications for Startups, Innovation, and Investment," we’ll delve into the potential impacts of this legislation on the Medtech ecosystem. Our panelists will discuss how startups can navigate the new regulatory landscape, what the Act means for innovation, and how it might influence investment decisions moving forward. Featured Panelists: • Sophie Ehrlich (Moderator) — EIT Health • Anjany Sekuboyina — bonescreen • Andreu M. Climent — Corify • Andreas Schriefl — eMurmur • Jordina Arcal Cunillera — mjn-neuro Join us at LSI Europe ‘24 this September 16-20th to see more panel sessions like this and connect with hundreds of global Medtech and Healthtech leaders in Sintra, Portugal. Apply on our website today while space is still available.

If you want to learn more about how we are transforming bone disease diagnosis, listen to one of our co-founders sharing some insights on X Ray Tech 's Skeleton Crew podcast. https://lnkd.in/dDi56kPV

Do you want to transform diagnostics and preventive care with evidence-based AI? 🏥 Join Bonescreen as a (Senior) Machine Learning Engineer in beautiful Munich 🚀 👩💻 🥨 🌞 🏔 👉 https://lnkd.in/dV3fEUzY and send your CV to career@bonescreen.de Or, if you know someone who knows someone who knows someone... 🤗

This World Osteoporosis Day, marked on October 20th, we’ll be spreading the message ‘SAY NO TO FRAGILE BONES’ – our bones are priceless and deserve to be handled with care! WOD is the perfect time to boost #bonehealth awareness and understanding of the need for #osteoporosis prevention and management. The campaign will drive action in the fight against osteoporosis and fragility fractures by reaching out to the public, patients, caregivers, healthcare professionals and health authorities. You can participate too! Organize an informational event or lecture at your hospital or university, give press interviews, share social media, host a walk, or simply leverage the numerous posters and other resources on our website for your local campaigns. For ideas to kickstart your campaign planning, download our Posters and the Campaign Toolkit with examples for national societies, fracture liaison services, healthcare authorities and companies. #WorldOsteoporosisDay https://lnkd.in/dh6SCzX

International Osteoporosis Foundation

🚀 Bonescreen joins TUM Venture Labs I Healthcare ✨ At TUM Venture Labs, the Bonescreen Team can integrate into a vibrant ecosystem of innovation, entrepreneurship, and cutting-edge research. Needless to say, we look forward to this collaboration! #Innovation #DeepTech #LifeSciences #TUMVentureLabs #BonescreenGmbH EIT Health Technical University of Munich

🤝🤖 Innovating Spine Surgery 🦴 👩💻 Bonescreen is partnering with LEM Surgical AG to advance the development of the next generation of spine surgical robots. As part of this collaboration, Bonescreen is contributing its expertise in machine learning to support LEM's cutting-edge technology. Both partners are committed to integrating the latest advancements in robotics, automation, and spine imaging to improve patient care. 🏥 👨⚕️

We warmly welcome the following new member companies to IOF’s Committee of Corporate Advisors (CCA): Angitia Biopharmaceuticals , IBEX Innovations , bonescreen and Anlene ( Fonterra ). Thank you for joining us – your support makes a difference! We’d also like to take this opportunity to once again thank all our CCA members for their valued support, which is so essential to IOF’s missions encompassing advocacy, health professional education, public awareness, and patient care. Together we are working towards a shared vision of a world without fragility fractures! Curious about joining the IOF CCA and making an impact? Explore opportunities and connect with us by contacting isabelle.ragain@osteoporosis.foundation . Learn more about the IOF CCA Committee here: https://bit.ly/3delQ2F

Viewport Meta

IPhone / Mobile Compatible

Google Tag Manager

Apple Mobile Web Clips Icon

Google Font API

Google Analytics

Content Delivery Network

WordPress

Global Site Tag

Font Awesome

Project Manager

Florence Daubiné

France Companies With More Than $1M in Revenue (Top 10K)

Europe Biotechnology Companies (Top 10K)

Pays de la Loire Companies With More Than $1M in Revenue

Private Pays de la Loire Companies

Atlantic Bone Screen Company, a biotechnology company, engages in developing a preclinical platform that allows the identification and evaluation of therapeutic drugs in osteoarticular pathologies to the pharmaceutical, biotechnological, and chemical industries. It offers in vitro services, such as various biological assays, including chondrocytes, osteoblasts, osteoclasts, and tumor cell lines based on osteoarticular cell models from human and animal origin; and in vivo services, which include various experimental models that reproduce the processes of bone resorption, as well as models of human bone pathologies. The company was founded in 2005 and is based in Nantes, France.

Nantes

Pays de la Loire

France

Europe

Atlantic Bone Screen

Atlantic Bone Screen offers in-vivo assays using rodent and large animal models to evaluate the behavior of drug candidates, nutraceuticals, and biomaterials in tumoral and non-tumoral diseases, as well as biocompatibility.

Atlantic Bone Screen provides in-vitro assays to evaluate the efficacy, osteogenesis, and cytotoxicity of drug candidates, nutraceuticals, biomaterials, and medical devices using various cell types including osteoclasts, osteoblasts, chondrocytes, and tumoral cells.

Atlantic Bone Screen offers histopathology, immunohistochemistry, and cytology services across a broad range of species and organ systems.

Atlantic Bone Screen develops and evaluates biomaterials implantation models in bone defects or intermuscular sites.

Atlantic Bone Screen provides image analysis services using microCT for 3D analysis, radiography for 2D analysis, and various microscopy techniques to evaluate bone architecture and the effects of compounds.

Atlantic Bone Screen offers rodent housing services in regulatory conditions, ensuring animal welfare and compliance with the 3R's principles.

news impact assignment basic	general
public peers	general	Nov 14, 2024 1:10 PM	bc1b2c99
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 14, 2024 1:10 PM	d2bbb1b5
crunchbase trigger	general	Nov 14, 2024 1:10 PM	fabe970e
crunchbase profile	general	Nov 15, 2024 8:55 AM	2ca77016
li profile	general	Nov 14, 2024 1:10 PM	7e643e85
translate crunchbase fundingrounds	general	Nov 15, 2024 9:02 AM	41ec598c
peers	general	Nov 14, 2024 1:10 PM	1619f5ab
news basic	general	Nov 14, 2024 1:10 PM	e1374552
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BONE

DE:BONESCREEN

Bonescreen